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ABSTRACT: The influence of milling diaqua-bis(omeprazolate)-
magnesium dihydrate (DABOMD), an active pharmaceutical
ingredient (API), was investigated. DABOMD was processed in
a planetary ball mill at different milling times, from 1 to 300 min.
The milling process resulted in a prominent comminution (size
reduction) and amorphization of the API. DABOMD amorphiza-
tion was identified with various characterization techniques
including thermogravimetric analysis, differential scanning calo-
rimetry, powder X-ray diffraction, and attenuated total reflection-
Fourier transform infrared spectroscopy. The solid−solid crystal-
line to amorphous phase transformation is driven by compression,
shear stresses, and heat generated in the planetary ball mill. This
leads to distortion and breakage of hydrogen bonds, release of water molecules from the crystalline lattice of DABOMD and the
accumulation of defects, and eventually a collapse of the crystalline order. Model fitting of the kinetics of comminution and the
amorphization of DABOMD revealed a series of events: a rapid comminution at the start of milling driven by crystal cleavage of
DABOMD, followed by partial amorphization, which is driven by rapid water diffusion, and subsequently, a slow steady
comminution and amorphization.
1. INTRODUCTION
Milling is a very important operation for the comminution (size
reduction) and homogeneity of particles. It is often used in the
pharmaceutical industry to optimize the dissolution rate of
poorly soluble drugs, enhance the bioavailability, facilitate tablet
compression, and permit a more accurate dosing of the drugs.1−3
Nonetheless, excessive energy from the mill can lead to
crystalline lattice disruption and solid form transformations,
including amorphization.3−5 The physicochemical changes that
arise from the excessive energy during milling are referred to as
mechanochemistry, whereas the milling/grinding processes that
cause these changes are referred to as mechanical activation.6−10
The impact of mechanical activation remains unpredictable in
many ways. It is widely accepted that amorphization through a
milling process can improve the solubility of drugs. No
controlled studies have been conducted to cover all the aspects
of this transformation during milling. Hence, special consid-
eration of the possible amorphization of the drug during milling
is needed,11,12 including conducting a controlled experiment
and understanding the mechanisms of which such trans-
formations occur.
During milling, particles are reduced by impact, shear,
attrition, and compression or a combination of these stress
modes.13 The stresses arising might contribute to different
influences on the product. The mechanical activation of solid
pharmaceuticals is attributed to the change in their physical and
chemical properties including reactivity, solubility, and bioavail-
ability.14 The change induced in solid pharmaceutical reactivity
is associated with the formation of defects, distortion, and
disordering of the crystal structure and eventually the
disappearance of the order of the atoms and molecules present
in the crystal, i.e., the formation of amorphous material. For
instance, milling of Cephalexin results in the formation of
amorphous material, which attributes to enhancing its
dissolution rates.15 Similarly, milling of Griseofulvin leads to
the formation of amorphous material on its surface layers, which
also enhances its dissolution rate. Piroxicam is not soluble in
water, which implies it has lower bioavailability. Mechanical
treatment of the drug causes a change in the crystal structure of
Piroxicam as well as in its reactivity, which increases the drug
solubility four times compared to the nonmilled compound.16
In addition to the formation of amorphous material,
mechanical activation can promote the transition from one
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crystalline form to another. For instance, the polymorphic
transition from a metastable form of Carbamazepine to the
stable β-form leads to a reduction in compressibility and
enhanced stability. The extent of change caused to the drug as a
result of milling the API depends on the condition under which
milling is performed as well as the API material properties.
To investigate the impact of mechanical treatment on a
crystalline solid pharmaceutical, one should consider the glass-
forming ability (formation of amorphous) and the physical
stability since this will allow screening for the most stable
compound to avoid any potential recrystallization before the
process of analysis. Mahlin et al. 2013 developed a model to
predict the glass-forming ability and physical stability and found
that samples that possess a large molecular weight (Mw > 300 g/
mol) and a high glass transition temperature can form an
amorphous form with long lasting stability (≥1 month).17 On
the basis of this model and on other aspects including safety and
costs, a candidate API was chosen for the mechanical treatment
study. Diaqua-bis(omeprazolate)-magnesium dihydrate (DA-
BOMD) (Figure 1), which is the salt form of omeprazole and
sold under the brand Losec, was selected for this work.
Omeprazole (IUPAC name 6-methoxy-2-[(4-methoxy-3,5-
dimethyl-2-pyridyl)methylsulfonyl]-1H-benzimidazole) is a
pharmaceutical drug developed for the treatment of stomach
acid reflux and gastrointestinal inflammatory-related dis-
eases.18,19 In this work, a planetary ball mill (Figure 2) was
employed for mechanical activation since it has been commonly
reported for inducing amorphization as a result of the high
energy involved in the process of size reduction. Examples of
pharmaceuticals reported to change from crystalline to
amorphous phase upon planetary ball milling include
Linaprazan,20 Budesonide,21 Sulfathiazole,22,23 Indomethacin,15
and Fananserine.24
2. MATERIALS AND METHODS
2.1. Materials. In this work, two solid-state forms of DABOMD
were used, a crystalline and an amorphous powder. The crystalline
powder of racemic DABOMD (R- and S-form) with 98% purity was
provided by AstraZeneca.
Amorphous powder of DABOMD was prepared from a DABOMD/
methanol solution (approximately 18 g in 0.7 L) followed by a rapid
evaporation in a rotary evaporator at 40 °C and 20 mbar. Subsequently,
the product was further dried in a vacuum (10 mbar). The amorphous
form was confirmed by the absence of Braggs peaks in powder X-ray
diffraction (PXRD).
2.2. Methods. 2.2.1. Milling Experiment. DABOMD crystalline
powder was milled using a Retsch PM100 planetary ball mill (PBM).
The powder samples were milled between 1 and 300 min at a speed of
650 rpm in 250 mL steel jar using four 15 mm diameter at a ball to
powder ratio (BPR) of 10:1 by weight. The BPR allows for increased
contacts and better particle breakage and size reduction.25
2.2.2. Powder Characterization. The nonmilled and the milled
samples were characterized to determine their morphological, size,
crystalline, and thermodynamic properties, in addition to the
intermolecular characteristics from the crystal structure.
Morphology. Surface and morphological properties of DABOMD
were examined using scanning electron microscope (SEM) in a Carl
Zeiss EVO MA15 scanning electron microscope at 20 kV in
backscattered imaging mode. Carbon tabs were coated with powder
samples and placed on SEM metal stubs. Sample stubs were sputter-
coated with a conductive layer of platinum before the analysis to
prevent charging.
Particles Size Analysis. The particle size distribution (PSD) was
analyzed by the laser diffraction method (in a Malvern 3000) of dry
sample powders. The powder was dispersed in air at a pressure of 2 bar,
a feed rate of 50%, and with obscuration ranging from 2 to 10%.
Figure 1. (Top) Molecular structure of diaqua-bis (Omeprazolate)-
magnesium dihydrate (DABOMD). Intermolecular hydrogen bonding
between the molecules in the lattice shown in blue dotted lines Mg:
green, S: yellow, N: blue, O: red, C: gray, H: white. Reproduced with
the permission of the International Union of Crystallography (IUCr).31
(Bottom) Hydrogen bond network in diaqua-bis (Omeprazolate)-
magnesium dihydrate (DABOMD). Mg: green, S: yellow, N: blue, O:
red, C: gray, H: white.
Figure 2. Schematic diagram of a planetary ball mill.
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Thermodynamic Properties. Differential scanning calorimetry
(DSC) analysis of the nonmilled and milled DABOMD was carried
out using a Mettler TC 3000 differential scanner calorimeter with
purged liquid nitrogen at a rate 5 °C/min from 25 to 250 °C.
Approximately 5−6 mg of powder was placed in an aluminum sealed
pan with a small hole in the top. Similarly, thermogravimetric analysis
(TGA) was carried out with a flowing gaseous nitrogen and a rate 5 °C/
min from 25 to 250 °C. TA Instruments Universal analysis 2000 was
used for the analysis step.
Crystalline Properties. The crystalline properties of the milled
powder were analyzed using powder X-ray diffraction (PXRD) with a
Phillips PW 1710 X-ray diffractometer using a Cu Kα radiation (λ =
0.14406 nm) operating with 40 kV accelerated voltage and 30 mA
current. Scans were collected over a 2θ range from 5° to 55°, scanned in
steps of 0.02°, with a dwell time of 0.25 s and 3° slit in front of the
detector.
Intermolecular Properties. Attenuated total reflectance-Fourier
transform infrared (ATR-FTIR) spectroscopy measurements were
carried out on an ATR-FTIR thermo iS101 to analyze the effect of
milling on the intermolecular properties of the sample. FTIR analysis of
the nonmilled powder, milled samples, and amorphous standard
powder was carried out at a range from 400 to 4000 cm−1. A
background spectrum was obtained for each experimental condition,
and 37 scans were taken for each sample. Computed IR spectra was
generated for a geometry optimized representative molecular model
system (see Figure S3 in the Supporting Information) using B3LYP-
D3/6-31G(d,p) as implemented in Jaguar 10.7.26 A few atomic
positions were fixed in the optimization in order to keep the feature of
the influence of the periodic crystal structure. This is a standard
procedure for modeling for example enzymatic reactions.27 These
positions are marked in Figure S3.
Quantification of Solid Phases. The mole fraction xj of crystalline
and amorphous DABOMD in samples taken before and after milling
was quantified using a chemometric linear combination of FTIR
spectra. All the quantifications were conducted in the MATLAB R201
software using a code that was previously established for the
measurement of different components in detergent powder mixtures
using near infrared (NIR).28 A spectrum consists of Nk intensities (I)
measured at a specific wavenumber (λk). Spectrum pretreatment was
carried out using first and second (dI′, dI″) derivatives to remove the
offset and baseline shifts arising from differing particle sizes28,29 as
shown in eqs 1 and 2.
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Calculation of the solid phases using FTIR spectra was conducted
according to the Johanson (2014)30 approach shown in eq 3. This
assumes the surface consists of either crystalline or amorphous
domains, and the intensity of reflected light is determined by the
surface area fraction of those two respective domains:
λ λ λ= + −I f f I f Id ( , ) d ( ) (1 ) d ( )mix.pred AAC AAC amp AAC cryst (3)
Here, fAAC is the area fraction of amorphous material on the surface of
the particles. The predicted first- or second-order derivative spectrum
dImix.pred (eqs 1 or 2) contains surface averaged contributions of the
derivatives of the amorphous and crystalline reference spectra dIamp and
dIcryst.
For a specific samples’ spectrum, the amorphous content fAAC is
obtained by minimization of the sum of residual differences squared
(SOS) between the experimental FTIR intensity of mixture dImix(λ)
and calculated value as displayed in eq 4.
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3. RESULTS AND DISCUSSION
3.1. Powder Characterization. 3.1.1. Morphology of
Particles. Representative SEM images of the nonmilled and
Figure 3. SEM images show the morphology of DABOMD, (a) nonmilled (×800), (b) nonmilled (×25000), (c) 300 minmilled (×800), (d) 300 min
milled (×25000).
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milled powders of DABOMD from 1 to 300 min are shown in
Figure 3 (Figures S1 and S2 in the Supporting Information). It
can be observed that the nonmilled particles have irregular
shapes with varying size distribution and some agglomerated
crystals (which are low in number but high in volume). As the
milling proceeds, the deagglomeration process takes place, but
some of the produced fine particles can be observed to adhere to
the surface of larger ones; see for example in Figure 3d.
3.1.2. Particle Size Distribution. The PSD, the cumulative
distribution, and the characteristic sizes of the nonmilled and the
milled powders of DABOMD are shown in Figures 4 and 5 as
well as in Table 1. The milling process caused a significant
reduction in D50 (median diameter) and D90 (diameter
representing 90% of the distribution) over time. The as-received
nonmilled material has a trimodal profile due to the presence of
particles with various sizes and some agglomerates which
transformed into a narrower profile centered around 10 μm as
the milling progressed. There was a significant size reduction
between the as-received nonmilled samples and the samples
milled for 300 min. The nonmilled sample had a D90 of 211 μm
and, the 300 min milled sample had a D90 of 35 μm.
Interestingly, the cumulative size distribution depicted in Figure
4 shows a significant size reduction between the nonmilled and
the 15 min milled samples due to the deagglomeration process,
followed by a steady size reduction between 15 and 300 min of
milling. Moreover, the PSD analysis shows that milling for 1 min
promotes some agglomeration that occurs as a result of the
formation and adhesion of fines to the larger particles. Analysis
of the fines concentration as a function of time showed negligible
variation inD10 (diameter representing 10% of the distribution),
which is likely to be within the resolution limit of the laser
diffraction measurement method.
3.1.3. Crystalline Properties. PXRD of crystalline nonmilled
DABOMD exhibits a series of sharp peaks corresponding to the
crystalline material, whereas that of standard amorphous
material possesses a typical halo peak with two broad maxima
at 2θ = 17.5° and 24° respectively as shown in Figure 6. As the
milling progresses, the PXRD patterns change rapidly with both
a reduction in intensity as well as broadening of the Bragg peaks
Figure 4. Particle size distribution of nonmilled and planetary ball
milled DABOMD from 1 to 300 min.
Figure 5. Cumulative particle size distribution of nonmilled and
planetary ball milled DABOMD from 1 to 300 min.
Table 1. Characteristic Sizes (D10, D50, and, D90) of
Nonmilled and Milled DABOMD Samples in Planetary Ball
Mill from 1 to 300 min
particle size (μm)
sample D10 D50 D90
nonmilled 1.5 21.2 211.0
1 min 1.5 16.4 180.0
5 min 1.7 12.7 98.1
15 min 1.7 11.2 66.9
30 min 1.7 9.9 58.9
60 min 1.7 9.9 51.8
120 min 1.6 8.7 45.6
180 min 1.7 8.7 40.1
300 min 1.5 7.5 35.3
Figure 6. PXRD of DABOMD before milling and after milling with a
planetary ball mill from 1 to 300 min.
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evident, which indicates a solid transition from crystalline to
amorphous. Beyond 60 min sharp Braggs peaks, characteristics
for a crystalline are absent, a typical scattering pattern for
materials without long-range order observed.
3.1.4. Thermodynamic Properties. DSC and TGA analyses
were performed to evaluate the effect of milling on the
thermochemical properties of DABOMD. For the crystalline
nonmilled sample, the TGA profile shown in Figure 7 has two
mass losses corresponding to two types of water interactions
present in the crystalline lattice. This was described in a previous
study.31 As the milling progresses, it appears that the amount of
mass loss detected by TGA reduces significantly with milling
time, which suggests that milling promotes dehydration,
reflected in the release of water molecules from the crystalline
lattice. This outcome agrees with the change in the crystalline
properties detected by PXRD. The TGA pattern obtained for
the milled samples (120 min and longer) of DABOMD is
analogous to that reported for amorphous Esomeprazole
magnesium32 prepared by vacuum drying. Similarly, it has
previously been suggested that sodium Omeprazole undergoes
amorphization as a result of drying.33
The DSC analysis of crystalline nonmilled DABOMD shows
three distinct thermal events: two endothermic and one
exothermic at 109 °C, 173 °C, and, 197.8 °C, respectively
(Figure 8). The first endothermic peaks represent a water loss
event, while the second endothermic peak corresponds to the
loss of more strongly bonded water. The third exothermic peak
represents the decomposition of DABOMD.31
As the milling progresses, the DSC profile for the milled
sample (Figure 8) shows that the peak intensity continuously
reduces with milling time and shifts to lower temperatures
consistent with a loss of crystallinity. The thermal behavior of
the longer milled sample is analogous to that of amorphous
Esomeprazole magnesium.32 Overall, thermochemical analyses
suggest that the phase transformation of DABOMD is driven by
the sequential dehydration processes during milling.
3.1.5. Intermolecular Interactions. The phase transforma-
tion from crystalline to amorphous occurs as a result of a change
in the molecular interactions. These interactions can be in the
form of hydrogen bonds, which play an important role in the
crystalline packing, in addition to weaker interactions such as
van der Waals interactions, or electrostatic interactions.34
Fourier transform infrared (FTIR) spectroscopy is sensitive to
the level of order and disorder present in the crystal structure,
including changes in hydrogen bonding35,36 and was used to
probe the impact of milling on the molecular structure together
with computational studies. Figures 9 and 10 show the FTIR
spectra of the crystalline nonmilled DABOMD, the amorphous
standard, and the milled samples. The vibrational frequencies of
some important functional groups of the crystalline nonmilled
DABOMD are shown in Table 2.
As the milling progresses, broadening and disappearance of
the FTIR peaks are evident for themilled samples (relative to the
spectra of crystalline samples). Samples milled for 300 min
exhibit very similar FTIR spectra to that of the reference
amorphous DABOMD. Consistent with the results obtained
Figure 7. TGA profile of DABOMD for the nonmilled and milled with a planetary ball mill at a temperature of 25−250 °C and a rate 5 °C/min.
Figure 8.DSC profile of DABOMD for the nonmilled andmilled with a
planetary ball mill at a temperature of 25−250 °C and a rate 5 °C/min.
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from PXRD, TGA, and DSC, the FTIR spectra thus confirm the
formation of the amorphous form by milling. Marked changes in
the spectral region’s diagnostics for hydrogen bonding are also
evident. The crystal structure (Figure 1a,b) shows that the two
different waters (W1 and W2) are hydrogen bond donating to
the pyridyl nitrogen (W2) and benzimidazole nitrogen (W1) of
the DABOMD,31 and in addition W1 and W2 form internal
hydrogen bonds. The peaks for the crystalline nonmilled
DABOMD are rather broad and not straightforward to
individually assign. To try to assist in this, we performed density
functional theory (DFT) calculations on a molecular system
mimicking the crystal structure (see Figure S3 in the Supporting
Information). From there, we observe that the vibrations
involving the two waters are strongly coupled making the
assignment of the experimental spectra with broad peaks
challenging. However, we can clearly assign peaks in the region
3300−3600 cm−1 to O−H stretch modes, involving both W1
and W2. In addition, we tentatively assign the O−H stretch of
W1 involving the hydrogen bonding to the benzimidazole
nitrogen to the broad peak at 3130 cm−1, but a more specific
assignment of other peaks was not possible. However, the
breaking of the hydrogen bonding pattern upon an elongated
milling time is evident from the marked changes in the FTIR
spectral regions corresponding to these O−H bands, in line with
earlier studies.33 The sharper peaks observed in the region 2800
to 3100 cm−1 we assign to mainly C−H stretches of the methyl
and methoxy groups on the aromatic systems. As shown below,
these groups are likely located at crystal cleavage planes and
hence are affected by the milling as shown by the peak
broadening. These FTIR results suggest that hydrogen bond
breaking is associated with the amorphization of DABOMD in
line with the TGA and DSC results of suggested hydrate water
loss taking place.
3.2. Mechanism of Amorphization. The combined
PXRD, DSC, TGA, and FTIR results revealed that DABOMD
amorphization during milling can be attributed to the
progressive release of water molecules. The distortion/breakage
of their hydrogen bonds eventually leads to the collapse of the
crystal lattice of DABOMD. There is a near absence of literature
Figure 9. FTIR-ATR of nonmilled and milled DABOMD showing
scans from (top) 600 to 950 cm−1, (bottom) from 950 to 1250 cm−1.
Figure 10. FTIR-ATR of nonmilled and milled DABOMD showing
scans from (top) 1200 to 1600 cm−1 and (bottom) from 2600 to 3700
cm−1
Table 2. Mode of Vibration for the Main Functional Groups
in DABOMD
functional group
type of
vibration
mode
crystalline
vibration
(cm−1)
amorphous
vibration
(cm−1)
300 min
milled
vibration
(cm−1)
O−H stretch 3300−3600 3070−3660 3070−3660
SO stretch 1001.2 993.9 994.9
C−H in CH3 or
O−CH3
stretch 2929.5 2934.1 2935.7
benzimidazole
H3C−O
bend 1197.7 1197.8 1198.1
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on studies probing the underlying mechanisms for amorphiza-
tion during milling of organic crystals. Understanding the
mechanically induced amorphization process requires a (i)
thorough knowledge of the milling conditions and (ii) the
underlying material properties of the feed, including its crystal
structure and mechanical properties.
(i) In a planetary ball mill, the energy supplied to the particles
gives rise to different forms of stress distribution including
compression stress by impact and rolling, and shearing
stress caused by sliding.37
(ii) The crystal structure of DABOMD involves hydrogen
bonds of different strengths, which hold the crystal lattice.
These stems from two loosely bonded water molecules
and two strongly bounded water molecules as discussed
earlier (Figure 1). Therefore, it can be suggested that the
impact and the shearing from the mill can cause
distortion/breakage of the hydrogen bonds and the
release of water molecules simultaneously, as was
indicated previously from the thermochemical and
intermolecular analyses. This can make the crystals
shear unstable and lead to the emergence of amorphous
DABOMD. Also, the kinetic energy and the heat
generated from the mill can increase the vibration of the
water molecules promoting dehydration, dislocation, and
accumulation of defects, hence speeding up the phase
transformation of DABOMD.
Moreover, as evaluated in our previous study,31 DABOMD
exhibits a crystal slip plane, the (100) plane with weak hydrogen
bonding across the plane (Figure 11). Other candidate slip
planes can be (011), (111̅), and (102) given that they hold
secondary morphological importance as shown in Table 3. Slip
planes are the planes incorporating the weakest interactions
between neighboring planes in the crystalline lattice. When the
crystal is subjected to stress, one would anticipate that the
deformation will usually occur through slip of the crystal planes
that are the easiest to displace, which promotes particle
fracture.38 Also, the dislocations and defects promote plastic
deformation, which will ultimately lead to amorphization.13
Analysis of the change in PXRD peaks upon milling shows that
the most significant intensity change occurs for the peak at 2θ =
5.4 as illustrated in Figure 12 and (Table S1 in Supporting
Information). This peak coincides with the major slip plane
(100) to be mostly affected, while the effect of other planes is
less straightforward to interpret. However, effects on the above-
mentioned (011), (111̅), and (102) planes are also observed. In
addition to the PXRD, the effect of crystal cleavage at plane
(100) is reflected in the FTIR peak changes at 2800−3100 cm−1,
which represents the methoxy and methyl group respectively,
which are designated around (100) (Figure 11). Therefore, we
postulate that the shear and impact from milling causes the
crystal to be cleaved along the easiest slip planes, and at a later
stage also affect the hydrogen bond breakage, which leads to
further crystalline disorder and amorphization. Therefore, it can
Figure 11. Visualization of the potential (100) slip plane in DABOMD crystal.
Table 3. DABOMD Important Morphological Planes Based
on the Attachment Energy (Eatt) Calculations
a
(h k l) multiplicity dhkl (Å) total Eatt (kcal mol
−1) area (%)
(1 0 0) 2 16.43 −25.8 59.4
(0 1 1) 4 6.89 −75.9 21.5
(1 1 1̅) 4 6.80 −78.8 9.0
(1 1 0) 4 7.23 −80.9 2.0
(1 0 2̅) 2 7.08 −101.7 8.1
aReproduced with the permission of the International Union of
Crystallography (IUCr).31
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be observed that milling has not only led to physical change of
DABOMDbut also caused a change reflected in the dehydration
process. Another example of where mechanical activation leads
to a form change is ampicillin trihydrate, which transforms into
the amorphous form upon grinding. Takahashi et al. (1984)
suggested that the freed water molecules from dehydration
caused by grinding leads to the collapse of the crystal lattice.39
Various researchers have suggested amorphization as a result
of vitrification (melt quench) at the surface.40 Thermal PXRD
was employed to evaluate the effect of the temperature increase
(from 25 to 170 °C) on the mechanochemistry of DABOMD. It
appears from Figure 13 that the crystallinity starts to effectively
vanish above 120 °C, which suggests that high temperature can
be a contributing factor to the amorphization of DABOMD. The
temperature contribution is composed of the bulk temperature
and the localized temperature. The bulk temperature is the
temperature of the mill, which was measured by the authors of
ref 41 who found that the highest temperature obtained was 80
°C. The localized temperature is the temperature generated on
the submicron regions on the impacting surfaces, which can be
much higher than the bulk temperature, but it is very difficult to
measure.8
In summary, the amorphization of DABOMD is therefore
associated with the following events: crystal cleavage via slip of
planes, water loss, accumulation of defects, and distortion of the
hydrogen bonds holding the crystal backbone as a result of
stresses and temperature experienced during the milling process.
The order of these events has been further investigated with a
study of the kinetics. Slip of planes can promote particle fracture
and creation of new surfaces. The release of water molecules can
create dislocation sites that facilitate the slip, accumulation of
defects, and plastic deformation. Increased temperatures can
lead to dehydration, increased atomic mobility, and hence
distortion of the crystalline lattice and may also lead to surface
melt and formation of amorphous upon cooling.
3.3. Kinetics of Comminution and Amorphization.
Prolonged milling of DABOMD resulted in significant (i)
comminution represented by a change in D90 (Table 1) and (ii)
large amorphization indicated by amorphous content (AAC)
detected by FTIR chemometric analysis (Table 4) and 50%
water loss (WL), indicated from TGA quantification (Table 4).
The changes in comminution, amorphization, and the amount
of water follow an exponential pattern as shown in
(experimental) Figure 14, panels a, b, and c, respectively.
Looking at Figure 14a (experimental), it appears that the process
of comminution depicts two sequential processes: a rapid
comminution (first 15 min), and a slow comminution. Similarly,
Figure 14b (experimental) representing the amorphization
process shows two sequential processes; a rapid amorphization
and a slow amorphization process. Interestingly the water loss
process (Figure 14c) also seems to occur in two sequential
events; a rapid water loss and a slow water loss event. This
further enhances the interpretation that loss of water is
associated with the change of DABOMD.
In order to facilitate a quantitative description of the
comminution, amorphization, and water loss events, we
represent the mechanisms with parallel first order processes
characterized by a time constant. This is first applied to the D90;
we define the extent of comminution, xcom, as the fraction of
change in D90 compared to the total change in its value. The
extent that comminution reduces from 1 to zero in an
exponential fashion that could be modeled as a two parallel
Figure 12. Identification of planes involved in the crystalline disorder of
DABOMD.
Figure 13.Thermal controlled PXRD of DABOMD from 25 to 170 °C.
Table 4. Percentage Amorphous Quantified Using the FTIR
ChemometricMethod ofMilled DABOMD and Equivalent %
Water Content from TGA
amorphous content % water content
milling time (min) first derivative second derivative TGA
0 0 0 8.7
1 0.101 0.12 8.3
5 0.356 0.223 7.7
15 0.713 0.632 7.2
30 0.828 0.712 6.5
60 0.908 0.708 5.9
120 0.933 0.822 5.3
180 0.999 0.977 4.7
240 0.999 0.943 4.3
300 1 0.961 4.2
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rate process because their time constants vary by an order of
magnitude:
α α
= −
−
= + −τ τ
∞
_
−
_
−_ _
x
D t D
D D
( )
e (1 )e
com
o
o
rpd com
t/
rpd com
t/rpd com slw com
(5)
Here, D(t) is the D90 of the milled sample at time t, and Do, D∞,
the D90 at the start and end of the milling process, respectively.
The time constants τrpd_com, τfrac are the time scales for rapid
comminution. Figure 14b (modeled) two parallel processes for
the loss of crystallinity (amorphization), characterized here by
the extent of crystallinity, xcryst which is obtained from the
apparent amorphous content, fAAC(t) as determined from the
chemometric analysis of the FTIR data as outlined in section
2.2.2.
α α
= −
−
−
= + −τ τ
∞
_
−
_
−_ _
x
f t
1
( ) AAC
AAC AAC
e (1 )e
cryst
AAC o
o
rpd amp
t/
rpd amp
t/rpd amp slw com
(6)
Here, AACo, fAAC(t), and AAC∞ are the apparent amorphous
content of the milled sample at time t = 0, t and at the end of the
milling period respectively.
For completeness, the parameters αrpd_com, αrpd_amp and time
constants τrpd_com, τslw_com, and τrpd_amp in eqs 5 and 6 were
quantified by minimizing the sum of squares between the
measured and predicted extend of comminution and crystal-
linity according to eq 7:
∑
∑
= [ − ]
+ [ − ]
=
=
x t x t
x t x t
SOS ( ) ( )
( ) ( ))
i
i i
i
i i
1
9
com.meas com.calc
2
1
9
cryst.meas cryst.calc
2
(7)
The water loss event can be modeled by fitting it to the rate
constants representing the extent of comminution as shown in
eq 8.
= + +τ τ− −_ _e e%water 4.27(1 0.74 0.26 )t t/ /rpd amp slw com (8)
The outcome of fitting the data shows the following:
The model fitted to the comminution data (Figure 14 a,
modeled) results in αrpd_com = 81%, τrpd_com = 3.6 min, and
τslw_com = 88.3 min; this confirms that rapid comminution
accounts for 80% of the extent of comminution. The slower
comminution occurs at a much slower time scale (88.3 min),
which indicates that if comminution is considered complete
when xcom < 1%, then, the comminution is complete after
approximately 300 min (xcom = 0.2e
−300/88). It is worth noting
that the time scale τ represents the inverse of the rate constant k.
The time scale allows us to see the sequence of events.
The model fitted to the amorphization data (Figure 14b,
modeled) resulting in αrpd_amp = 79% and τrpd_amp = 8 min. The
final time constant is identical to the time scale of rapid
comminution in eq 5 which emphasizes that about 80% of
amorphization occurs in the first few minutes of milling.
The model fitted to the water content data (Figure 14c,
modeled) shows that at τrpd_amp = 8 min, the % water = 1.106,
Figure 14. Experimental and modeled comminution and amorphization of DABOMD with respect to time.
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which is equivalent to 15% water loss during the first event (in
the first 15min of milling as was indicated by TGA). This further
enhances that water loss is clearly associated with the rapid
amorphization since they both occur at the same time scale of ca.
8 min.
We can finally propose a comprehensive mechanism that
shows the sequential events occurring during the milling of
DABOMD following Figure 15. (1) We believe that the first
process that occurs at the time scale of 4 min is the crystal
cleavage via slip of planes, which accounts for the rapid
comminution (size reduction + deagglomeration) which creates
a large number of fresh surfaces and defects. (2) The created
surfaces allow for fast diffusion reflected in the rapid evaporation
of water molecules from the crystalline lattice. The deformation
of planes, dislocation, and mobility of the water molecules cause
breakage and disruption of the hydrogen bonds in the lattice
accounting for the rapid amorphization observed in the time
scale of 8 min. (3) The slower event of comminution is
attributed to decrease of the number of slip planes and the
amount of generated defect. This implies that fewer surfaces are
available for water diffusion, which explains the drop of water
dehydration and hence slower amorphization.
4. CONCLUSION
The study of mechanochemistry is very limited in pharmaceut-
icals materials. This paper describes a combined experimental
and modeling approach to investigate the mechanochemistry of
DABOMD. The experimental work involved milling DABOMD
at different times in a planetary ball mill and carrying out a full
characterization of the feed and the product morphological,
crystalline, thermodynamic, and intermolecular properties.
Milling of DABOMD causes a prominent comminution within
60min of milling. Amathematical model fit of comminution and
the amorphization were performed to evaluate the kinetic
aspects that DABOMD undergoes upon milling. The outcome
of the fit shows that initially, 80% of the particle’s comminution
occurs by crystal cleavage via the slip of planes occurring in a
time scale of 4 min. This is followed by a rapid dehydration (of
approximately 20% of the water content), which occurs within a
time scale of 8 min. The planes deformation along with rapid
dehydration of water results in loss of 80% of the crystallinity,
with the remaining 20% lost during subsequent comminution in
a time scale of 100 min, resulting from limited slip planes and
surfaces available for water diffusion. The method applied
connects the intrinsic characteristics of the particles at the
molecular level (i.e., crystalline structure, mechanical proper-
ties) and the bulk properties that can be influenced by process
parameters (type of stress, energy, time). The implementation of
this methodology requires an in-depth understanding of the
underlying intrinsic material properties at the molecular level,
which was performed in previous work and knowledge of the
milling environment and parameters. This approach can be
successfully applied in the study of any change arising with
milling, i.e., comminution and or/mechanochemistry, and can
also be implemented in other pharmaceutical processes.
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